A type I interferon footprint in pre-operative biopsies is an independent biomarker that in combination with CD8<sup>+</sup> T cell quantification can improve the prediction of response to neoadjuvant treatment of rectal adenocarcinoma.

Oncoimmunology · 2023 · PMC10173792 · PMID 37180638

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Although our attempts to use CD3 and/or CD8 densities to predict the response to neoadjuvant treatment did not reach statistical significance, our use of the IS B tool resulted in similar results to those previously published 7 .

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.